1 Ning ZW, Zhai LX, Peng J, Zhao L, Huang T, Lin CY, Chen WH, Luo Z, Xiao HT, Bian ZX. Simultaneous UPLC-TQ-MS/MS determination of six active components in rat plasma: application in the pharmacokinetic study of Cyclocarya paliurus leaves. Chin Med. 2019;14:28.
2 Yao ZH, Qin ZF, He LL, Wang XL, Dai Y, Qin L, Gonzalez FJ, Ye WC, Yao XS. Identification, bioactivity evaluation and pharmacokinetics of multiple components in rat serum after oral administration of Xian-Ling-Gu-Bao capsule by ultra performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry. J Chromatogr B. 2017;1041-1042:104-12.
3 Yan R, Yang Y, Chen Y. Pharmacokinetics of Chinese medicines: strategies and perspectives. Chin Med. 2018;13:24.
4 Lu T, Yang J, Gao X, Chen P, Du F, Sun Y, Wang F, Xu F, Shang H, Huang Y, Wang Y, Wan R, Liu C, Zhang B, Li C. Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine. Drug Metab Dispos. 2008;36(8):1578-86.
5 Cheng C, Du F, Yu K, Xu F, Wang F, Li L, Olaleye OE, Yang J, Chen F, Zhong C, Liu Q, Li J, Wang Z, Li C, Xiao W. Pharmacokinetics and Disposition of Circulating Iridoids and Organic Acids in Rats Intravenously Receiving ReDuNing Injection. Drug Metab Dispos. 2016;44(11):1853-8.
6 Lu Q, Li CL. Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: A meta-analysis. Life Sci. 2018;210:9-19.
7 He ZF, Wang JJ, Wang WD. Effect of Kangý ai Injection on Serum Level of Soluble Interleukin-2 Receptor and Vascular Endothelial Growth Factor in Patients with Esophageal Carcinoma during Radiotherapy. Chin J Integr Med. 2006;12(4):273-6.
8 Wan YM, Li YH, Xu ZY, Wu HM, Xu Y, Yang M, Wu XN. The Effect of Transarterial Chemoembolization in Combination With Kang'ai Injection on Patients With Intermediate Stage Hepatocellular Carcinoma: A Prospective Study. Integr Cancer Ther. 2018;17(2):477-85.
9 Jia M, Zhang B, Qi Y, Yang J, Yao Z, Qin Z, Zhang X, Yao X. Ultra high-performance liquid chromatography coupled with mass spectrometry and chemometric analysis of Kang-Ai injection based on the chemical characterization, simultaneous quantification and relative quantification of forty-seven herbal alkaloids and saponins. J Sep Sci. 2020; DOI: 10.1002/jssc.201900878.
10 Yang J, Dai G, Hou Y, Song Z, Wang F, Ji G, Chen J. Quantification of oxymatrine in rat plasma by UPLC-MS/MS to support the pharmacokinetic analyses of oxymatrine-loaded polymersomes. Anal Methods. 2014;6(6):1811-7.
11 Wu XL, Hang TJ, Shen JP, Zhang YD. Determination and pharmacokinetic study of oxymatrine and its metabolite matrine in human plasma by liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal. 2006;41(3):918-24.
12 Xu M, Yin J, Xie L, Zhang J, Zou C, Zou J, Liu F, Ju W, Li P. Pharmacokinetics and tolerance of toal astragalosides after intravenous infusion of astragalosides injection in healthy Chinese volunteers. Phytomedicine. 2013;20(12):1105-11.
13 Jin Y, Guo X, Yuan B, Yu W, Suo H, Li Z, Xu H. Disposition of Astragaloside IV via Enterohepatic Circulation Is Affected by the Activity of the Intestinal Microbiome. J Agric Food Chem.2015;63(26):6084-93.
14 Zhang WD, Zhang C, Liu RH, Li HL, Zhang JT, Mao C, Moran S, Chen CL. Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs. Life Sci. 2006;79(8):808-15.
15 Ran R, Zhang C, Li R, Chen B, Zhang W, Zhao Z, Fu Z, Du Z, Du X, Yang X, Fang Z. Evaluation and Comparison of the Inhibition Effect of Astragaloside IV and Aglycone Cycloastragenol on Various UDP-Glucuronosyltransferase (UGT) Isoforms. Molecules. 2016;21(12):1616.
16 Olaleye OE, Niu W, Du FF, Wang FQ, Xu F, Pintusophon S, Lu JL, Yang JL, Li C. Multiple circulating saponins from intravenous ShenMai inhibit OATP1Bs in vitro: potential joint precipitants of drug interactions. Acta Pharmacol Sin. 2018;40(6):833-49.
17 Yao Z, Li S, Qin Z, Hong X, Dai Y, Wu B, Ye W, Gonzalez FJ, Yao X. Characterization of human UDP-glucuronosyltransferases responsible for glucuronidation and inhibition of norbakuchinic acid, a primary metabolite of hepatotoxicity and nephrotoxicity component bakuchiol in Psoralea corylifolia L. RSC Adv. 2017;7:52661-71.
18 Gao L, Qin Z, Zhang B, Yin Z, Yang XZJ. An investigation of the metabolic activity, isozyme contribution, species differences and potential drug–drug interactions of PI-103, and the identification of efflux transporters for PI-103-Oglucuronide in HeLa1A9 cells. RSC Adv. 2020;10:9610-22.
19 Sun ZH, Chen J, Song YQ, Dou TY, Zou LW, Hao DC, Liu HB, Ge GB, Yang L. Inhibition of human carboxylesterases by ginsenosides: structure-activity relationships and inhibitory mechanism. Chin Med. 2019;14:56.
20 Ge G. Deciphering the metabolic fates of herbal constituents and the interactions of herbs with human metabolic system. Chin J Nat Med. 2019;17(11):801-2.
21 Lv X, Xia Y, Finel M, Wu J, Ge G, Yang L. Recent progress and challenges in screening and characterization of UGT1A1 inhibitors. Acta Pharm Sin B. 2019;9(2):258-78.
22 Zhou QH, Zhu YD, Zhang F, Song YQ, Jia SN, Zhu L, Fang SQ, Ge GB. Interactions of drug-metabolizing enzymes with the Chinese herb Psoraleae Fructus. Chin J Nat Med. 2019;17(11):858-70.
23 US Food and Drug Administration, Guidance for Industry, Bioanalytical Method Validation, 2013 http://www.fda.gov/downloads/drugs/.
24 Matuszewski BK, Constanzer ML, Chavez-Eng CM. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal Chem. 1998;70(5):882-9.
25 Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659-61.
26 Guo B, Li C, Wang G, Chen L. Rapid and direct measurement of free concentrations of highly protein-bound fluoxetine and its metabolite norfluoxetine in plasma. Rapid Commun Mass Spectrom. 2006;20(1):39-47.
27 He W, Wu JJ, Ning J, Hou J, Xin H, He YQ, Ge GB, Xu W. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice. Toxicol In Vitro. 2015;29(7):1569-76.
28 Xin H, Qi XY, Wu JJ, Wang XX, Li Y, Hong JY, He W, Xu W, Ge GB, Yang L. Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases. Food Chem Toxicol. 2016;90:112-22.
29 Huang LH, Zhong YM, Xiong XH, Cen MF, Cheng XG, Wang GX, Chen JS, Wang SJ. The Disposition of Oxymatrine in the Vascularly Perfused Rat Intestine-Liver Preparation and Its Metabolism in Rat Liver Microsomes. J Pharm Sci. 2016;105(2):897-903.
30 Lin P, Dai Y, Yao Z, Qin Z, He L, Wang Q, Wei Z, Zhang Y, Yao X. Metabolic profiles and pharmacokinetics of Qingre Xiaoyanning capsule, a traditional Chinese medicine prescription of Sarcandrae Herba, in rats by UHPLC coupled with quadrupole time-of-flight tandem mass spectrometry. J Sep Sci. 2019;42(4):784-96.
31 Liu XW, Yang JL, Niu W, Jia WW, Olaleye OE, Wen Q, Duan XN, Huang YH, Wang FQ, Du FF, Zhong CC, Li YF, Xu F, Gao Q, Li L, Li C. Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity. Acta Pharmacol Sin. 2018;39(12):1935-46.
32 Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res. 1993;10(7):1093-5.
33 Halim CE, Xinjing SL, Fan L, Bailey Vitarbo J, Arfuso F, Tan CH, Narula AS, Kumar AP, Sethi G, Ahn KS. Anti-cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models. Pharmacol Res. 2019;147:104327.
34 Rashid HU, Xu Y, Muhammad Y, Wang L, Jiang J. Research advances on anticancer activities of matrine and its derivatives: An updated overview. Eur J Med Chem. 2019;161:205-38.
35 Li L, Hou X, Xu R, Liu C, Tu M. Research review on the pharmacological effects of astragaloside IV. Fundam Clin Pharmacol. 2017;31(1):17-36.
36 Mancuso C, Santangelo R. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food Chem Toxicol. 2017;107(Pt A):362-72.
37 Liu W, Shi J, Zhu l, Dong l, Luo F, Zhao M, Wang Y, Hu M, Lu l, Liu Z. Reductive metabolism of oxymatrine is catalyzed by microsomal CYP3A4. Drug Des Devel Ther. 2015;9:5771-83.
38 Yang Z, Gao S, Yin T, Kulkarni KH, Teng Y, You M, Hu M. Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method. J Pharm Biomed Anal. 2010;51(5):1120-7.
39 Evans WE, Relling MV. Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics. Science. 1999;286(5439):487.
40 Miners JO, Mackenzie PI, Knights KM. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential. Drug Metab Rev. 2010;42(1):196-208.
41 Seong SJ, Kang WY, Heo JK, Jo J, Choi WG, Liu KH, Lee S, Choi MK, Han YH, Lee HS, Ohk B, Lee HW, Song IS, Yoon YR. A Comprehensive In Vivo and In Vitro Assessment of the Drug Interaction Potential of Red Ginseng. Clin Ther. 2018;40(8):1322-37.
42 Pan X, Wang L, Gründemann D, Sweet DH. Inhibition of human organic cation transporters by the alkaloids matrine and oxymatrine. Fitoterapia. 2014;92:206-10.
43 Li X, Hu J, Wang B, Sheng L, Liu Z, Yang S, Li Y. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: Herb–drug interactions mediated via P-gp. Toxicol Appl Pharmacol. 2014;275(2):163-75.
44 Zhang G, Ou R, Li F, Wu J, Zheng L, Tong Y, Liu Y, Liu Z, Lu L. Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions. J Ethnopharmacol. 2016;180:104-13.
45 Zhang W, Liu M, Yang L, Huang F, Lan Y, Li H, Wu H, Zhang B, Shi H, Wu X. P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice. Molecules. 2019;24(3):561.
46 Zhan T, Yao N, Wu L, Lu Y, Liu M, Liu F, Xiong Y, Xia C. The major effective components in Shengmai Formula interact with sodium taurocholate co-transporting polypeptide. Phytomedicine. 2019;59:152916.
47 Lee S, Kwon M, Choi MK, Song IS. Effects of Red Ginseng Extract on the Pharmacokinetics and Elimination of Methotrexate via Mrp2 Regulation. Molecules. 2018;23:2948.
48 Li N, Wang D, Ge G, Wang X, Liu Y, Yang L. Ginsenoside metabolites inhibit P-glycoprotein in vitro and in situ using three absorption models. Planta Med. 2014;80(4):290-6.
49 Zhang Q, Li FJ, Jin RM, Song ZP. Study on the hepatotoxicity induced by matrine and oxymatrine. Chinese Archives of Traditional Chinese Medicine 2011;29:1222-5.